Galecto, Inc. filed an 8-K on February 10, 2026, reporting a public offering of 14,473,685 shares at $19.00 each, raising approximately $295.9 million to support its operations into Phase 3 development of DMR-001, with an additional 2,171,052 shares available to underwriters within 30 days. The offering is set to close on February 12, 2026.